ARCHIMED Acquires Arkstone to Boost AI Clinical Decision Market
Arkstone, an innovative biotechnology company democratizing infectious disease expertise and fighting antimicrobial resistance, has been acquired by global healthcare private equity firm ARCHIMED, which now...